California SB6 addresses the presence of xylazine in the illicit drug market, aiming to prevent its spread while ensuring access for veterinary use.

California SB6 focuses on the growing presence of xylazine, an animal sedative not approved for human use, in the state's illicit drug supply. The bill aims to prevent the escalation of the opioid epidemic by addressing the increasing number of overdose deaths linked to xylazine. It ensures that animal drugs containing xylazine remain available for veterinary use, crucial for legitimate medical purposes.

California SB6 addresses the presence of xylazine in the illicit drug market, aiming to prevent its spread while ensuring access for veterinary use.

California SB6 focuses on the growing presence of xylazine, an animal sedative not approved for human use, in the state's illicit drug supply. The bill aims to prevent the escalation of the opioid epidemic by addressing the increasing number of overdose deaths linked to xylazine. It ensures that animal drugs containing xylazine remain available for veterinary use, crucial for legitimate medical purposes.